Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections

被引:16
作者
Wargo, Kurt A. [1 ]
McCreary, Erin K. [1 ]
English, Thomas M. [2 ]
机构
[1] Auburn Univ, Harrison Sch Pharm, Huntsville, AL 35801 USA
[2] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA
关键词
vancomycin; clindamycin; Eagle effect; skin; abscess; SOFT-TISSUE INFECTIONS; RENAL-FAILURE; PENICILLIN; THERAPY;
D O I
10.1093/cid/civ462
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Acute bacterial skin and skin-structure infections (ABSSSIs) are common causes of hospital admissions. These infections are often caused by methicillin-resistant Staphylococcus aureus; therefore, vancomycin remains a commonly used therapy. The purpose of this study was to compare hospital length of stay (LOS) in patients treated with vancomycin monotherapy vs combination therapy with clindamycin for ABSSSIs. Methods. This was a retrospective analysis of 269 patients admitted with ABSSSIs to a 941-bed hospital in northern Alabama. Patients who received either vancomycin monotherapy or vancomycin in combination with clindamycin were included. The primary outcome was hospital LOS; secondary outcomes included 90-day readmission rate and the impact of the following on the primary outcome: organisms cultured, presence of abscess, incision and debridement (I&D), failure of a trial of outpatient antibiotics, and presence of diabetes. Results. Hospital LOS was similar between groups when evaluating all ABSSSIs (3.7 +/- 1.5 days vs 4.0 +/- 2.0 days, P = .192, combination and monotherapy, respectively). In patients with abscesses, combination therapy was significantly associated with decreased LOS by 18.2% compared with monotherapy (95% confidence interval [CI], 0.818 [. 679 to .985]; P = .034). Among the entire population, significantly fewer patients in the combination group were readmitted within 90 days (5.3% vs 15.3%; P = .006; odds ratio [OR], 3.2; 95% CI [1.35 to 7.66]). The 90-day readmission rates were significantly lower among patients with abscesses as well (2.0% vs 24.3%; P = .0001; OR, 14.6; 95% CI [2.98 to 71.37]). Conclusions. Combination therapy with vancomycin and clindamycin was associated with decreased hospital LOS for patients with an abscess. The 90-day hospital readmission rates for those with ABSSSIs may be reduced when combination therapy is utilized. A larger, prospective, multicentered study is needed to validate these findings.
引用
收藏
页码:1148 / 1154
页数:7
相关论文
共 15 条
[1]  
[Anonymous], 2014, NEW ENGL J MED, V371, P1160
[2]   Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].
Bellomo, R ;
Ronco, C ;
Kellum, JA ;
Mehta, RL ;
Palevsky, P .
CRITICAL CARE, 2004, 8 (04) :R204-R212
[3]   Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection [J].
Boucher, Helen W. ;
Wilcox, Mark ;
Talbot, George H. ;
Puttagunta, Sailaja ;
Das, Anita F. ;
Dunne, Michael W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (23) :2169-2179
[4]   A 55-year-old man with fever, renal failure, and hip pain [J].
Clay, AS ;
Behnia, M .
CHEST, 2001, 119 (01) :281-284
[5]   Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections [J].
Corey, G. Ralph ;
Kabler, Heidi ;
Mehra, Purvi ;
Gupta, Sandeep ;
Overcash, J. Scott ;
Porwal, Ashwin ;
Giordano, Philip ;
Lucasti, Christopher ;
Perez, Antonio ;
Good, Samantha ;
Jiang, Hai ;
Moeck, Greg ;
O'Riordan, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (23) :2180-2190
[6]   Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin A release [J].
Coyle, EA ;
Cha, R ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (05) :1752-1755
[7]   THE MULTIPLE MECHANISMS OF PENICILLIN RESISTANCE [J].
EAGLE, H .
JOURNAL OF BACTERIOLOGY, 1954, 68 (05) :610-616
[8]   Trends in US Hospital Admissions for Skin and Soft Tissue Infections [J].
Edelsberg, John ;
Taneja, Charu ;
Zervos, Marcus ;
Haque, Nadia ;
Moore, Carol ;
Reyes, Katherine ;
Spalding, James ;
Jiang, Jenny ;
Oster, Gerry .
EMERGING INFECTIOUS DISEASES, 2009, 15 (09) :1516-1518
[9]   The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020 [J].
Gilbert, David N. ;
Guidos, Robert J. ;
Boucher, Helen W. ;
Talbot, George H. ;
Spellberg, Brad ;
Edwards, John E., Jr. ;
Scheld, W. Michael ;
Bradley, John S. ;
Bartlett, John G. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) :1081-1083
[10]   Skin and Soft-Tissue Infections Requiring Hospitalization at an Academic Medical Center: Opportunities for Antimicrobial Stewardship [J].
Jenkins, Timothy C. ;
Sabel, Allison L. ;
Sarcone, Ellen E. ;
Price, Connie S. ;
Mehler, Philip S. ;
Burman, William J. .
CLINICAL INFECTIOUS DISEASES, 2010, 51 (08) :895-903